rosiglitazone has been researched along with strontium in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dumas, V; Fournier, C; Guignandon, A; Laroche, N; Perrier, A; Rattner, A; Thomas, M; Vico, L | 1 |
1 other study(ies) available for rosiglitazone and strontium
Article | Year |
---|---|
Reduction by strontium of the bone marrow adiposity in mice and repression of the adipogenic commitment of multipotent C3H10T1/2 cells.
Topics: Adipogenesis; Adiposity; Animals; Bone and Bones; Bone Marrow; Butadienes; Cell Lineage; Cell Proliferation; Cyclin D1; Extracellular Matrix; Extracellular Signal-Regulated MAP Kinases; Fibronectins; Gene Expression Regulation; Male; MAP Kinase Signaling System; Mesenchymal Stem Cells; Mice; Multipotent Stem Cells; Nitriles; Organ Size; PPAR gamma; Radiography; RNA, Messenger; Rosiglitazone; Strontium; Thiazolidinediones | 2012 |